Mitochondria in lung disease
Open accessThe DOI matches its Crossref record; 150 of the 151 references it cites were found in a registry or an index.
Abstract
Mitochondria are a distinguishing feature of eukaryotic cells. Best known for their critical function in energy production via oxidative phosphorylation (OXPHOS), mitochondria are essential for nutrient and oxygen sensing and for the regulation of critical cellular processes, including cell death and inflammation. Such diverse functional roles for organelles that were once thought to be simple may be attributed to their distinct heteroplasmic genome, exclusive maternal lineage of inheritance, and ability to generate signals to communicate with other cellular organelles. Mitochondria are now thought of as one of the cell's most sophisticated and dynamic responsive sensing systems. Specific signatures of mitochondrial dysfunction that are associated with disease pathogenesis and/or progression are becoming increasingly important. In particular, the centrality of mitochondria in the pathological processes and clinical phenotypes associated with a range of lung diseases is emerging. Understanding the molecular mechanisms regulating the mitochondrial processes of lung cells will help to better define phenotypes and clinical manifestations associated with respiratory disease and to identify potential diagnostic and therapeutic targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the recent past, a number of studies have investigated the contribution of mitophagy to COPD pathogenesis, leading to discordant findings (Cloonan & Choi, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Cloonan & Choi, 2016
Citations
Cites
5 retracted
UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
Moon, J.-S., Lee, S., Park, M.-A., Siempos, I. I., Haslip, M., Lee, P. J., Yun, M., Kim, C. K., Howrylak, J., Ryter, S. W., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78253 · Cited by 238
Self-citationRetractedMitochondrial DNA induces inflammation and increases TLR9/NF-κB expression in lung tissue
ZHANG, J.-Z., LIU, Z., LIU, J., REN, J.-X., & SUN, T.-S. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1650 · Cited by 194 · cited 2×
“Activates the NLRP3 inflammasome intracellularly (86, 88) and activates neutrophils, vascular endothelial cells (90), and AMs extracellularly (40, 91) Stimulates TGF-β 1 from AECs (92) Activates the NLRP3 inflammasome (86, 88) and cGAS (89) Circulating mtDNA as plasma biomarker in medical ICU…”
BackgroundRetractedRedox regulation of mitophagy in the lung during murine Staphylococcus aureus sepsis
Chang, A. L., Ulrich, A., Suliman, H. B., & Piantadosi, C. A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.10.582 · Cited by 111
RetractedLI, H., FENG, Z., WU, W., LI, J., ZHANG, J., & XIA, T. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2103 · Cited by 64
RetractedOkoye, I., Wang, L., Pallmer, K., Richter, K., Ichimura, T., Haas, R., Crouse, J., Choi, O., Heathcote, D. A., Lovo, E., et al. (2015) · Science · doi:10.1126/science.aaa7516 · Cited by 52
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“Such metabolic switching, a phenomenon also referred to as the Warburg effect (26), is also observed in non–small cell lung cancer (NSCLC), a type of lung cancer that accounts for 85% of all lung cancers and originates from bronchial/epithelial cells (27).”
BackgroundMizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Self-citationMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
Research works printed but not linked: 2
- European Respiratory Society, 2013, European Lung White Book
- 10.1172/JCI21146 · doi:10.1172/jci21146 · Paper page
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationOxidative stress-based therapeutics in COPD
Barnes, P. J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101544 · Cited by 497
“There is an increase in mitochondrial mass, fusion and disruption of mitochondria with mitochondrial membrane leakiness [93].”
BackgroundThe aging lung: Physiology, disease, and immunity
Schneider, J. L., Rowe, J. H., Garcia-de-Alba, C., Kim, C. F., Sharpe, A. H., & Haigis, M. C. (2021) · Cell · doi:10.1016/j.cell.2021.03.005 · Cited by 500
“Selective removal of damaged mitochondria via mitophagy also plays an important role in lung aging and age-related pulmonary disease (Cloonan and Choi, 2016).”
Chronic inflammation and the hallmarks of aging
Baechle, J. J., Chen, N., Makhijani, P., Winer, S., Furman, D., & Winer, D. A. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101755 · Cited by 471
A Molecular Approach to Mitophagy and Mitochondrial Dynamics.
Yoo, S., & Jung, Y. (2018) · PubMed · doi:10.14348/molcells.2018.2277 · Cited by 441
“Thus, the role of mitophagy in lung disease depends on the cell type (Cloonan and Choi, 2016).”
BackgroundAlveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
Parimon, T., Yao, C., Stripp, B. R., Noble, P. W., & Chen, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072269 · Cited by 375
Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function
Yu, G., Tzouvelekis, A., Wang, R., Herazo-Maya, J. D., Ibarra, G. H., Srivastava, A., de Castro, J. P. W., DeIuliis, G., Ahangari, F., Woolard, T., et al. (2018) · Nature Medicine · doi:10.1038/nm.4447 · Cited by 356
“Recently, there has been significant interest in mitochondrial function in chronic lung diseases 9,11,32 .”
Oxidative Stress in Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2022) · Antioxidants · doi:10.3390/antiox11050965 · Cited by 281
“Mitochondria are dysfunctional in COPD, with an increase in mitochondrial mass, fusion, and increased membrane leakiness due to impairment of mitophagy, which normally removes damaged mitochondria and may itself be impaired by oxidative stress [26,115].”
BackgroundChernyak, B. V., Popova, E. N., Prikhodko, A. S., Grebenchikov, O. A., Zinovkina, L. A., & Zinovkin, R. A. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920120068 · Cited by 280
Mitochondrial Dysfunction in Airway Disease
Prakash, Y. S., Pabelick, C. M., & Sieck, G. C. (2017) · Chest · doi:10.1016/j.chest.2017.03.020 · Cited by 258
Overview of the Mechanisms of Oxidative Stress: Impact in Inflammation of the Airway Diseases
Albano, G. D., Gagliardo, R. P., Montalbano, A. M., & Profita, M. (2022) · Antioxidants · doi:10.3390/antiox11112237 · Cited by 256
“Superoxide produced by mitochondria is a result of incomplete reduction of oxygen to water due to leakage of electrons by a mitochondrial respiratory chain, which is represented by four complexes composed of proteins, labeled I through IV: respiratory complexes I (aka NADH:ubiquinone oxidoreductase), II (aka succinate…”
BackgroundDela Cruz, C. S., & Kang, M.-J. (2018) · Mitochondrion · doi:10.1016/j.mito.2017.12.001 · Cited by 255
The Role of Mitophagy in Innate Immunity
Gkikas, I., Palikaras, K., & Tavernarakis, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01283 · Cited by 239
“Therefore, mitophagy impacts organismal health and disease in a context- and dose-dependent fashion (66, 140, 155, 156).”
BackgroundEvolving and Expanding the Roles of Mitophagy as a Homeostatic and Pathogenic Process
Gustafsson, Å. B., & Dorn, G. W. (2019) · Physiological Reviews · doi:10.1152/physrev.00005.2018 · Cited by 228
Inflammation mechanism and research progress of COPD
Xu, J., Zeng, Q., Li, S., Su, Q., & Fan, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1404615 · Cited by 200
“This is manifested by increased mitochondrial mass, fusion, and leaky mitochondrial membranes, phenomena that result from an impaired autophagic mechanism that scavenges damaged mitochondria (i.e., mitochondrial autophagy) (85).”
BackgroundGestational Hypoxia and Developmental Plasticity
Ducsay, C. A., Goyal, R., Pearce, W. J., Wilson, S., Hu, X.-Q., & Zhang, L. (2018) · Physiological Reviews · doi:10.1152/physrev.00043.2017 · Cited by 198
Mitochondrial quality control in pulmonary fibrosis
Larson-Casey, J. L., He, C., & Carter, A. B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101426 · Cited by 189
“tional factors, such as 5' adenosine monophosphate-activated protein kinase (AMPK) and nuclear factor erythroid 2-related factor 1/2 (Nrf1/ 2) can also be involved [14].”
BackgroundMitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains
Culley, M. K., & Chan, S. Y. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120847 · Cited by 180
MOTS-c: a novel mitochondrial-derived peptide regulating muscle and fat metabolism
Lee, C., Kim, K. H., & Cohen, P. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.05.015 · Cited by 178
“MOTS-c is also implicated in lung [66] and heart disease [67].”
Backgroundvan der Vliet, A., Janssen-Heininger, Y. M. W., & Anathy, V. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.08.001 · Cited by 167
Mitochondrial dynamics and mitophagy in lung disorders
Sharma, A., Ahmad, S., Ahmad, T., Ali, S., & Syed, M. A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119876 · Cited by 158
Alloreactivity and allorecognition of syngeneic and allogeneic mitochondria
Ramirez-Barbieri, G., Moskowitzova, K., Shin, B., Blitzer, D., Orfany, A., Guariento, A., Iken, K., Friehs, I., Zurakowski, D., del Nido, P. J., et al. (2019) · Mitochondrion · doi:10.1016/j.mito.2018.03.002 · Cited by 156
The Role of Exercise and TFAM in Preventing Skeletal Muscle Atrophy
Theilen, N. T., Kunkel, G. H., & Tyagi, S. C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25737 · Cited by 152
“The maternal genetics create the mitochondrial lineage of most animals (Cloonan and Choi, 2016).”
BackgroundIdentification of Cytotoxic Flavor Chemicals in Top-Selling Electronic Cigarette Refill Fluids
Hua, M., Omaiye, E. E., Luo, W., McWhirter, K. J., Pankow, J. F., & Talbot, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-38978-w · Cited by 149
Metabolic reprogramming, oxidative stress, and pulmonary hypertension
Pokharel, M. D., Marciano, D. P., Fu, P., Franco, M. C., Unwalla, H. J., Tieu, K., Fineman, J. R., Wang, T., & Black, S. M. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102797 · Cited by 163
“ygen sensing, excess ROS generation can be detrimental to cellular and organ health [23,155].”
BackgroundMitochondrial dysfunction in lung ageing and disease
Cloonan, S. M., Kim, K., Estèves, P., Trian, T., & Barnes, P. J. (2020) · European Respiratory Review · doi:10.1183/16000617.0165-2020 · Cited by 147
Self-citationThe cGAS‐STING pathway: The role of self‐DNA sensing in inflammatory lung disease
Ma, R., Serrano, T. P. O., Davis, J., Prigge, A. D., & Ridge, K. M. (2020) · The FASEB Journal · doi:10.1096/fj.202001607r · Cited by 152
Ryter, S. W., Rosas, I. O., Owen, C. A., Martínez, F. J., Choi, M. E., Lee, C. G., Elias, J. A., & Choi, A. M. K. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201808-585mg · Cited by 137
Self-citationAghapour, M., Remels, A. H. V., Pouwels, S. D., Bruder, D., Hiemstra, P. S., Cloonan, S. M., & Heijink, I. H. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00329.2019 · Cited by 133
Self-citationVeith, C., Boots, A. W., Idris, M., van Schooten, F., & van der Vliet, A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7742 · Cited by 121
“During differentiation from type II to type I AECs, type II AECs reduce the number and size of mitochondria to adapt to cellular stress, which results in lower energy demanding type I AECs (40).”
BackgroundInfluentialRegulation of the NLRP3 inflammasome by autophagy and mitophagy
Gupta, S., Cassel, S. L., Sutterwala, F. S., & Dagvadorj, J. (2024) · Immunological Reviews · doi:10.1111/imr.13410 · Cited by 132
“133,134 Numerous studies have underscored the significance of autophagy, mitophagy, and the NLRP3 inflammasome in the pathogenesis of ALI.”
Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
Burtscher, J., Cappellano, G., Omori, A., Koshiba, T., & Millet, G. P. (2020) · iScience · doi:10.1016/j.isci.2020.101631 · Cited by 120
Pokharel, M. D., Flores, A. G., Marciano, D. P., Franco, M. C., Fineman, J. R., Aggarwal, S., Wang, T., & Black, S. M. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103049 · Cited by 138
“One such plausible strategy is targeting mitochondria, as aberrant mitochondria appear to be a critical contributor to disease progression in many cell types and various pulmonary diseases [1].”
BackgroundMitochondria Signaling Pathways in Allergic Asthma
Qian, L., Nasab, E. M., Athari, S. M., & Athari, S. S. (2022) · Journal of Investigative Medicine · doi:10.1136/jim-2021-002098 · Cited by 121
Maremanda, K. P., Sundar, I. K., & Rahman, I. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114788 · Cited by 107
“The role of mitochondria accounting for the lung damage in the pathogenesis of lung diseases is gaining wide importance for therapeutic interventions [37].”
BackgroundAge-related mitochondrial dysfunction as a key factor in COVID-19 disease
Fernández‐Ayala, D. J. M., Navas, P., & López‐Lluch, G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111147 · Cited by 119
“Removal of dysfunctional mitochondria has been considered a key therapeutic process for the treatment of respiratory diseases (Cloonan and Choi, 2016).”
Liu, X., Zhao, X., Li, X., Lv, S., Ma, R., Qi, Y., Abulikemu, A., Duan, H., Guo, C., Li, Y., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.122608 · Cited by 105
Reversal of emphysema by restoration of pulmonary endothelial cells
Hisata, S., Racanelli, A. C., Kermani, P., Schreiner, R. P., Houghton, S., Palikuqi, B., Kunar, B., Zhou, A., Mcconn, K., Capili, A. M., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20200938 · Cited by 102
“Morphometry software quantified the length of chords (vertical lines within a grid) within areas identified as airspace (Laucho-Contreras et al., 2015; Cloonan and Choi, 2016).”
MethodInfluentialSelf-citationIslam, A. B. M. M. K., & Khan, M. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-76404-8 · Cited by 99
Mitochondrial dysfunction in human primary alveolar type II cells in emphysema
Kośmider, B., Lin, C.-R., Karim, L., Tomar, D., Vlasenko, L., Marchetti, N. T., Bolla, S., Madesh, M., Criner, G. J., & Bahmed, K. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.063 · Cited by 99
Roushandeh, A. M., Kuwahara, Y., & Roudkenar, M. H. (2019) · Cytotechnology · doi:10.1007/s10616-019-00302-9 · Cited by 88
Cheng, X.-Y., Li, Y., Huang, C., Li, J., & Yao, H. (2017) · Oncotarget · doi:10.18632/oncotarget.15116 · Cited by 90
Manevski, M., Muthumalage, T., Devadoss, D., Sundar, I. K., Wang, Q., Singh, K. P., Unwalla, H. J., Chand, H. S., & Rahman, I. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101443 · Cited by 92
“To prevent the release of these proinflammatory molecules cells have developed various defensive mechanisms including autophagosomal degradation of the damaged mitochondria via mitophagy [2,3,17,132].”
BackgroundMemon, A. A., Zöller, B., Hedelius, A., Wang, X., Stenman, E., Sundquist, J., & Sundquist, K. (2017) · Biomolecular Detection and Quantification · doi:10.1016/j.bdq.2017.08.001 · Cited by 83
“dysfunction, such as variations in copy number are associated with disease pathogenesis and/or progression are becoming increasingly important [21].”
BackgroundLow-dose cadmium disrupts mitochondrial citric acid cycle and lipid metabolism in mouse lung
Hu, X. Y., Chandler, J. D., Park, S., Liu, K., Fernandes, J., Orr, M. C., Smith, M. R., Ma, C., Kang, S., Uppal, K., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.005 · Cited by 78
“Altered mitochondrial function is increasingly recognized to contribute to lung disease involving inflammation [21,75,76].”
BackgroundImpairment of mitochondrial function by particulate matter: Implications for the brain
Chew, S., Kolosowska, N., Saveleva, L., Malm, T., & Kanninen, K. M. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104694 · Cited by 74
Sundar, I. K., Maremanda, K. P., & Rahman, I. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.09.022 · Cited by 72
“Thus, our data on CSE-induced mitochondrial dysfunction in primary lung epithelial cells corroborate with findings reported in ASM cells from patients with COPD.”
BackgroundInfluentialSupersulphides provide airway protection in viral and chronic lung diseases
Matsunaga, T., Sano, H., Takita, K., Morita, M., Yamanaka, S., Ichikawa, T., Numakura, T., Ida, T., Jung, M., Ogata, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40182-4 · Cited by 76
“In fact, supersulphides produced by CARS2/CPERS mediatetheelectrontransportchainandmaintainthebioenergeticsin a critical way 26,37,38 ; in addition, mitochondrial dysfunction may be involved in the pathogenesis of COPD 54,55 .”
COPD 2020: new directions needed
Barnes, P. J. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00473.2020 · Cited by 66
“Cellular senescence is associated with mitochondrial dysfunction and defective autophagy; dysfunctional mitochondria may be the major source of oxidative stress in COPD patients (12, 15).”
BackgroundBaker, J. R., Donnelly, L., & Barnes, P. J. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.01.027 · Cited by 69
Altitude and COVID‐19: Friend or foe? A narrative review
Millet, G. P., Debevec, T., Brocherie, F., Burtscher, M., & Burtscher, J. (2020) · Physiological Reports · doi:10.14814/phy2.14615 · Cited by 73
“Mitochondria of lung cells are required for efficient alveolar gas exchange and maintaining efficient ventilation (Cloonan & Choi, 2016; Piantadosi & Suliman, 2017).”
BackgroundMitochondrial CaMKII inhibition in airway epithelium protects against allergic asthma
Sebag, S. C., Koval, O. M., Paschke, J. D., Winters, C. J., Jaffer, O. A., Dworski, R., Sutterwala, F. S., Anderson, M. E., & Grumbach, I. M. (2017) · JCI Insight · doi:10.1172/jci.insight.88297 · Cited by 66
Sotty, J., Kluza, J., Sousa, C. D., Tardivel, M., Anthérieu, S., Alleman, L., Canivet, L., Perdrix, E., Loyens, A., Marchetti, P., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.105830 · Cited by 73
Burtscher, J., Burtscher, M., & Millet, G. P. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101976 · Cited by 70
“lung, chronic inhibition of mitochondrial respiration also leads to a metabolic switch to glycolysis, impedes alveolar gas exchanges and ventilator adaptation to match blood oxygen content with oxygen demand [87,88], leading to oxygen desaturation.”
Monitoring clinical progression with mitochondrial disease biomarkers
Steele, H. E., Horváth, R., Lyon, J. J., & Chinnery, P. F. (2017) · Brain · doi:10.1093/brain/awx168 · Cited by 70
“With secondary mitochondrial dysfunction arising in several of these conditions (Wallace, 2012; Yu et al., 2012; Begriche et al., 2013; Cloonan and Choi, 2016), alongside the association of diabetes with primary mitochondrial diseases, the application of metabolomics in genetically determined…”
BackgroundGuan, R., Cai, Z., Wang, J., Ding, M., Li, Z., Xu, J., Li, Y., Li, J., Yao, H., Liu, W., et al. (2019) · Aging · doi:10.18632/aging.102454 · Cited by 69
“The pathogenic role of mitochondrial dysfunction has increasingly been confirmed in a variety of human diseases including Parkinson’s, Alzheimer’s, cardiac dysfunction, pulmonary disorders as well as aging [37].”
BackgroundAutophagy alleviates mitochondrial DAMP-induced acute lung injury by inhibiting NLRP3 inflammasome
Peng, W., Peng, F., Yuanlei, L., Li, Y., Zhao, N., Shao, Q., Chen, J., Qian, K., Zeng, Z., Zhan, Y., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118833 · Cited by 66
Chegini, Z., Noei, M., Hemmati, J., Arabestani, M. R., & Shariati, A. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01347-2 · Cited by 76
“Actually, mtROS have the potential to modulate both the structure and function of mitochondria, leading to the disruption of normal cellular processes and the development of pathological conditions [77].”
BackgroundOxidative Stress Mechanisms in the Pathogenesis of Environmental Lung Diseases
Thimmulappa, R. K., Chattopadhyay, I., & Rajasekaran, S. (2019) · Springer eBooks · doi:10.1007/978-981-32-9366-3_5 · Cited by 76
Liu, Y., Merrill, R. A., & Strack, S. (2020) · Cells · doi:10.3390/cells9020298 · Cited by 64
“Mitochondria are critical for cell survival in acute injuries to the heart and lungs, in part due to their ability to regulate cellular ROS generation and sequestration [27,45,46].”
BackgroundDailah, H. G. (2022) · Molecules · doi:10.3390/molecules27175542 · Cited by 62
The mitochondria in lung fibrosis: friend or foe?
Malsin, E. S., & Kamp, D. W. (2018) · Translational research · doi:10.1016/j.trsl.2018.05.005 · Cited by 58
“can promote mitochondrial dysfunction and apoptosis that drives degenerative diseases, such as pulmonary fibrosis, malignant transformation, and aging.(9,22,23,27-29) Notably, as compared to nDNA, mtDNA is nearly 50fold more sensitive to oxidative damage largely due to its proximity to the ETC and ROS production, its…”
BackgroundInfluentialPseudomonas aeruginosa Induced Host Epithelial Cell Mitochondrial Dysfunction
Maurice, N. M., Bedi, B., Yuan, Z., Goldberg, J. B., Koval, M. H., Hart, C. M., & Sadikot, R. T. (2019) · Scientific Reports · doi:10.1038/s41598-019-47457-1 · Cited by 56
Key Functions and Therapeutic Prospects of Nur77 in Inflammation Related Lung Diseases
Banno, A., Lakshmi, S. P., Reddy, A. T., Kim, S. C., & Reddy, R. C. (2019) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.10.002 · Cited by 53
Jiang, C., Zhang, J., Xie, H., Guan, H., Li, R., Chen, C., Dong, H., Zhou, Y., & Zhang, W. K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112408 · Cited by 56
Akap1genetic deletion increases the severity of hyperoxia-induced acute lung injury in mice
Narala, V. R., Fukumoto, J., Hernández‐Cuervo, H., Patil, S. S., Krishnamurthy, S., Breitzig, M., Galam, L., Soundararajan, R., Lockey, R. F., & Kolliputi, N. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00365.2017 · Cited by 59
Fibrosis: Lessons from OMICS analyses of the human lung
Yu, G., Ibarra, G. H., & Kaminski, N. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.014 · Cited by 52
Safety and efficacy of platelet-derived mitochondrial transplantation in ischaemic heart disease
Baharvand, F., Roudkenar, M. H., Pourmohammadi-Bejarpasi, Z., Najafi-Ghalehlou, N., Feizkhah, A., Aliabadi, S. B., Salari, A., & Roushandeh, A. M. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132227 · Cited by 56
Yang, L., Na, C.-L., Luo, S., Wu, D. X.-Y., Hogan, S. P., Huang, T., & Weaver, T. E. (2017) · Scientific Reports · doi:10.1038/srep46416 · Cited by 55
Mitochondrial bioenergetics and pulmonary dysfunction: Current progress and future directions
Ten, V. S., & Ratner, V. I. (2019) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2019.04.001 · Cited by 59
Cytotoxicity and oxidative stress induced by atmospheric mono-nitrophenols in human lung cells
Khan, F., Jaoui, M., Rudzinski, K. J., Kwapiszewska, K., Martínez‐Romero, A., Gil-Casanova, D., Lewandowski, M., Kleindienst, T. E., Offenberg, J. H., Krug, J. D., et al. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.119010 · Cited by 50
“Mitochondrial dysfunction links to underlying lung pathologies, respiratory diseases, and apoptosis induced by mitochondrial-ROS (mtROS) (Cloonan and Choi, 2016; Liu et al., 2020; Piantadosi and Suliman, 2017).”
BackgroundA Mitochondrial Perspective of Chronic Obstructive Pulmonary Disease Pathogenesis
Kang, M., & Shadel, G. S. (2016) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2016.79.4.207 · Cited by 56
Pu, X., Ma, S., Gao, Y., Xu, T., Chang, P., & Dong, L. (2020) · Cells · doi:10.3390/cells10010042 · Cited by 48
“As documented, mitochondrial dysfunction is an important biological event that is closely associated with lung disease pathogenesis and/or progression [85].”
BackgroundCellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
Zhang, Y., & Wang, J. (2023) · Advances in respiratory medicine · doi:10.3390/arm91010005 · Cited by 53
“Impaired mitochondrial phagocytosis, DNA damage, increased reactive oxygen species, growth disturbance, dysfunction, and disturbance of homeostasis in AT2 cells all induce ER stress and programmed cell death in AT2 cells, leading to the development of fibrosis [46,47].”
BackgroundTong, Z., Du, X., Zhou, Y., Jing, F., Ma, J., Feng, Y., Lou, S., Wang, Q. A., & Dong, Z. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111075 · Cited by 52
Parkin-mediated mitophagy and autophagy flux disruption in cellular models of MERRF syndrome
Paz, M. V., Povea-Cabello, S., Villalón-García, I., Álvarez-Córdoba, M., Suarez-Rivero, J. M., Talaverón-Rey, M., Jackson, S., Falcón‐Moya, R., Moreno, A. R., & Sánchez-Alcázar, J. A. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165726 · Cited by 49
Ketogenesis promotes tolerance to Pseudomonas aeruginosa pulmonary infection
Tomlinson, K. L., Chen, Y.-T., Junker, A., Urso, A., Lung, T. W. F., Ahn, D. S., Hofstaedter, C. E., Baskota, S. U., Ernst, R. K., Prince, A. S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.09.001 · Cited by 41
Su, Y., Guo, H., & Liu, Q. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0321-545rr · Cited by 46
Role of mitochondria in inflammatory lung diseases
Narala, V. R., Narala, S. R., Subramani, P. A., Panati, K., & Kolliputi, N. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1433961 · Cited by 50
“Cloonan and Choi (2016) examined how oxidative stress leads to mitochondrial damage and how this is implicated in COPD.”
BackgroundInfluentialZhu, X., Wang, F., Lei, X., & Dong, W. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220975106 · Cited by 39
Targeting the mitochondria in chronic respiratory diseases
Chellappan, D. K., Paudel, K. R., Tan, N. W., Cheong, K. S., Khoo, S. S. Q., Seow, S. M., Chellian, J., Candasamy, M., Patel, V. K., Arora, P., et al. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.09.003 · Cited by 43
The potential of lipid-polymer nanoparticles as epigenetic and ROS control approaches for COPD
Chikuma, K., Arima, K., Asaba, Y., Kubota, R., Asayama, S., Sato, K., & Kawakami, H. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1696965 · Cited by 42
Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease: Unraveling the Molecular Nexus
Li, C.-L., Liu, J.-F., & Liu, S. (2024) · Biomedicines · doi:10.3390/biomedicines12040814 · Cited by 52
“The disruption of the energetic equilibrium maintained by mitochondria emerges as a crucial factor in the pathophysiology of COPD, contributing significantly to the observed cellular dysfunction [15,16].”
BackgroundMichelini, S., Mawas, S., Kurešepi, E., Barbero, F., Šimunović, K., Miremont, D., Devineau, S., Schicht, M., Ganin, V. S., Haugen, Ø. P., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03419-6 · Cited by 40
The interplay between mitophagy and mitochondrial ROS in acute lung injury
Zhong, Y., Xia, S., Wang, G., Liu, Q., Ma, F., Yu, Y., Zhang, Y., Qian, L., Hu, L., & Xie, J. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101920 · Cited by 41
Omaiye, E. E., Luo, W., McWhirter, K. J., Pankow, J. F., & Talbot, P. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00266 · Cited by 36
How dietary advanced glycation end products could facilitate the occurrence of food allergy
Paparo, L., Coppola, S., Nocerino, R., Pisapia, L., Picariello, G., Cortese, M., Voto, L., Maglio, M., Miele, E., Carucci, L., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.11.023 · Cited by 44
The role of Staphylococcus aureus enterotoxin B in chronic rhinosinusitis with nasal polyposis
Chegini, Z., Didehdar, M., Khoshbayan, A., Karami, J., Yousefimashouf, M., & Shariati, A. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00839-x · Cited by 40
“In fact, mtROS could regulate the mitochondrial structure and function, generate a malfunctioned cycle, and develop disease pathophysiology [50].”
Main, E. N., Cruz, T. M., & Bowlin, G. L. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad070 · Cited by 37
Zhang, X., Wang, T., Yuan, Z., Dai, L., Zeng, N., Wang, H., Liu, L., & Wen, F. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00466.2017 · Cited by 38
“Recent studies have revealed that MTDs participate in activating the innate immune response of the lung (5).”
Ventilator-induced diaphragm dysfunction in critical illness
Liu, Y.-Y., & Li, L. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218811950 · Cited by 39
“The downregulation of oxidative phosphorylation but upregulation of glycolysis, reduction in mitochondrial membrane potential, cytochrome c leak into the cytosol, and constitutive opening of mitochondrial pores have all been associated with apoptosis pathways.(54,55) The NF-jB signaling pathway, a primary transcriptio…”
BackgroundEndosomes and Autophagy: Regulators of Pulmonary Endothelial Cell Homeostasis in Health and Disease
Chichger, H., Rounds, S., & Harrington, E. O. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7817 · Cited by 35
“Damaged organelles, such as mitochondria (59) and cilia (42), can be disposed off through autophagy (14) in chronic obstructive pulmonary disease.”
BackgroundHan, Y. K., Kim, J. S., Lee, G. B., Lim, J. H., & Park, K. M. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102077 · Cited by 33
“In cells, mitochondria. a major ROS-producing intracellular organelle, normally undergo fusion and fission to adapt to physiological and pathological conditions.”
BackgroundInfluentialPGAM5 is a key driver of mitochondrial dysfunction in experimental lung fibrosis
Ganzleben, I., He, G.-W., Günther, C., Prigge, E., Richter, K., Rieker, R. J., Mougiakakos, D., Neurath, M. F., & Becker, C. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03133-1 · Cited by 35
“Given the importance of mitochondria in the pathogenesis of inflammatory and fibrotic pulmonary diseases [13], we decided to investigate the role of the mitochondrial protein PGAM5 in the pathogenesis of pulmonary fibrosis.”
BackgroundYu, K., Pan, J., Husamelden, E., Zhang, H., He, Q., Wei, Y., & Tian, M. (2020) · Chemistry - An Asian Journal · doi:10.1002/asia.202001100 · Cited by 32
Immunomodulatory role of mitochondrial DAMPs: a missing link in pathology?
Garg, M., Johri, S., & Chakraborty, K. (2022) · FEBS Journal · doi:10.1111/febs.16563 · Cited by 36
“Moreover, impaired mitochondrial health is known to aggravate asthma and COPD severity [92].”
He, Q., Li, P., Han, L., Yang, C. G., Jiang, M., Wang, Y., Han, X., Cao, Y., Liu, X., & Wu, W. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00362.2023 · Cited by 42
Yoon, Y. H., Yeon, S. H., Choi, M. R., Jang, Y., Kim, J. A., Oh, H.-W., Xu, J., Park, S. K., Heo, J. Y., Rha, K., et al. (2020) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2020.12.4.653 · Cited by 34
Mohanan, A., Washimkar, K. R., & Mugale, M. N. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119676 · Cited by 39
Lee, S.-Y., Moon, J., Lee, A. R., Moon, Y., Choi, J. W., Lee, C. R., Jeon, S. H., Sohn, H. S., Youn, J., Shin, D., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01376-y · Cited by 34
Metadata
- Authors
- Cloonan, S. M., & Choi, A. M. K.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Corresponding author
- Choi, Augustine M.K.
- Venue
- Journal of Clinical Investigation
- Published
- 2016-03-01
- Volume
- 126
- Issue
- 3
- Pages
- 809-820
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4767339
- OpenAlex
- W2291366038
- Cited by
- 322
- References
- 151
- Citations by year
- 2026: 31 · 2025: 44 · 2024: 35 · 2023: 25 · 2022: 38 · 2021: 38 · 2020: 44 · 2019: 26 · 2018: 24 · 2017: 14 · 2016: 3
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Lung Association
- National Institutes of Health (HL105339)
- College of Veterinary Medicine, Cornell University
- National Heart, Lung, and Blood Institute (R01HL055330, R00HL125899, R01HL079904, R01HL060234, P01HL105339, P0-HL105339, K99HL125899, P01HL114501)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Keywords
- mitochondria, lung disease, mitochondrial dysfunction, oxidative phosphorylation, heteroplasmy, maternal inheritance, cell death, inflammation, energy metabolism, mitochondrial signaling, therapeutic target
- MeSH terms
- Animals, Energy Metabolism, Humans, Inflammation, Lung Diseases, Mitochondria, Second Messenger Systems, Mitochondrial Dynamics, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.